Parathyroid hormone, vitamin D, and general and abdominal adiposity in bariatric surgery candidates : A cross-sectional analysis of the Tehran Obesity Treatment Study
7 affiliations
- 1Student Research Committee, School of Medicine, Alborz University of Medical Sciences, Karaj, Iran
- 2Neuroscience Research Center, Iran University of Medical Sciences, Tehran, Iran
- 3Obesity Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran
- 4Tehran Obesity Treatment Center, Department of Surgery, Faculty of Medicine, Shahed University, Tehran, Iran
- 5Clinical Research and Development Center, Department of Nephrology, Shahid Modarres Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
- 6Department of Community Medicine, School of Medicine, Alborz University of Medical Sciences, Karaj, Iran
- 7Non-communicable Diseases Research Center, Alborz University of Medical Sciences, Karaj, Iran.
Abstract
Obesity is commonly accompanied by low circulating 25-hydroxyvitamin D [25(OH)D], potentially because of volumetric dilution, adipose distribution, and obesity-related changes in 25(OH)D metabolism. Parathyroid hormone (PTH) and 25(OH)D are linked through calcium–phosphate homeostasis and renal conversion of 25(OH)D to calcitriol, but whether 25(OH)D statistically accounts for the association between PTH and adiposity remains uncertain. The data derived from the baseline visit of 4822 participants Tehran Obesity Treatment Study was used to examine the relationship between PTH and 25(OH)D with obesity using regression models. Furthermore, a mediation analysis using potential-outcomes framework was carried out using the aforementioned factors to obtain direct effect of PTH and mediated effect of 25(OH)D on body mass index (BMI) and waist circumference (WC). Higher PTH and lower 25(OH)D were associated with greater adiposity. Compared with the lowest PTH category, PTH > 72.8 pg/mL was associated with 1.89 kg/m2 higher BMI, higher odds of morbid obesity (odds ratio: 1.66, 95% confidence interval: 1.33–2.09), and 1.67 cm greater WC. Compared with 25(OH)D < 12 ng/mL, concentrations > 35 ng/mL were associated with 1.81 kg/m2 lower BMI, lower odds of morbid obesity (odds ratio: 0.60, 95% confidence interval: 0.48–0.75), and 3.30 cm lower WC. For a PTH increase from 10 to 65 pg/mL, 25(OH)D mediated 7% of the total association with BMI and 9% with WC. Higher PTH and lower 25(OH)D were associated with BMI and WC. Exploratory decomposition suggested that circulating 25(OH)D accounted for only a small portion of the PTH–adiposity association. These findings support careful preoperative mineral-metabolism phenotyping and evaluation of abnormal PTH, but do not establish direction or causality within this framework.
Related
- Professional group differences in general and abdominal adiposity: the roles of sex and age in a retrospective cross-sectional study
- Association between self-reported resistance-exercise frequency and abdominal adiposity among Chinese adults: a cross-sectional study
- A CAP–ALT–HbA1c Model for Biopsy-Confirmed Moderate-to-Severe Hepatic Steatosis in Bariatric Surgery Candidates: Development and Internal Validation
- Abdominal Adiposity and Lacunar Stroke: A Mendelian Randomization Mediation Study
- Correlation patterns between lifetime mood spectrum, impulsivity, and disordered eating behaviors in candidates to bariatric surgery
BibTeX
@article{aghajanian2026parathyroid,
title = {{Parathyroid hormone, vitamin D, and general and abdominal adiposity in bariatric surgery candidates : A cross-sectional analysis of the Tehran Obesity Treatment Study}},
author = {Sepehr Aghajanian and Maryam Barzin and Safa Saleh Nia and Fateme Mohammadifard and Majid Valizadeh and Alireza Khalaj and Amirhesam Alirezaei and Mahmood Bakhtiyari},
journal = {Medicine},
year = {2026},
month = oct,
doi = {10.1097/md.0000000000051362},
url = {https://europepmc.org/article/PMC/PMC13727271},
note = {CC BY},
}
RIS
TY - JOUR
TI - Parathyroid hormone, vitamin D, and general and abdominal adiposity in bariatric surgery candidates : A cross-sectional analysis of the Tehran Obesity Treatment Study
AU - Sepehr Aghajanian
AU - Maryam Barzin
AU - Safa Saleh Nia
AU - Fateme Mohammadifard
AU - Majid Valizadeh
AU - Alireza Khalaj
AU - Amirhesam Alirezaei
AU - Mahmood Bakhtiyari
PY - 2026
DA - 2026/10/30
JO - Medicine
DO - 10.1097/md.0000000000051362
UR - https://europepmc.org/article/PMC/PMC13727271
AB - Obesity is commonly accompanied by low circulating 25-hydroxyvitamin D [25(OH)D], potentially because of volumetric dilution, adipose distribution, and obesity-related changes in 25(OH)D metabolism. Parathyroid hormone (PTH) and 25(OH)D are linked through calcium–phosphate homeostasis and renal conversion of 25(OH)D to calcitriol, but whether 25(OH)D statistically accounts for the association between PTH and adiposity remains uncertain. The data derived from the baseline visit of 4822 participants Tehran Obesity Treatment Study was used to examine the relationship between PTH and 25(OH)D with obesity using regression models. Furthermore, a mediation analysis using potential-outcomes framework was carried out using the aforementioned factors to obtain direct effect of PTH and mediated effect of 25(OH)D on body mass index (BMI) and waist circumference (WC). Higher PTH and lower 25(OH)D were associated with greater adiposity. Compared with the lowest PTH category, PTH > 72.8 pg/mL was associated with 1.89 kg/m2 higher BMI, higher odds of morbid obesity (odds ratio: 1.66, 95% confidence interval: 1.33–2.09), and 1.67 cm greater WC. Compared with 25(OH)D < 12 ng/mL, concentrations > 35 ng/mL were associated with 1.81 kg/m2 lower BMI, lower odds of morbid obesity (odds ratio: 0.60, 95% confidence interval: 0.48–0.75), and 3.30 cm lower WC. For a PTH increase from 10 to 65 pg/mL, 25(OH)D mediated 7% of the total association with BMI and 9% with WC. Higher PTH and lower 25(OH)D were associated with BMI and WC. Exploratory decomposition suggested that circulating 25(OH)D accounted for only a small portion of the PTH–adiposity association. These findings support careful preoperative mineral-metabolism phenotyping and evaluation of abnormal PTH, but do not establish direction or causality within this framework.
SN - 0304-5412
SN - 1536-5964
SN - 0025-7974
ER -